Sfoglia per AUTORE
SANTOLERI F
Collezione ASL Torino 4
Items : 5
Drug utilization and medication adherence for the treatment of psoriatic arthritis: an Italian study. in Global & regional health technology assessment / Glob Reg Health Technol Assess. 2024 Oct 9;11:191-199. doi: 10.33393/grhta.2024.3204. eCollection 20
2024
ASL Torino 4
ASL Torino 4
Santoleri F; Abrate P; Pestrin L; Pasut E; Modesti G; Musicco F; Fulgenzio C; Zuzolo E; Pieri G; Roperti M; Gazzola P; Gambera M; Martignoni I; Montresor V; Guarino F; Grossi L; Di Fabio L; Roberti C; Spoltore C; Tinari G; De Rosa S; Giannini R; Langella R; Mingolla G; Piccoli M; Costantini A;
Medication adherence reporting in pivotal clinical trials: overview of oral oncological drugs. in European journal of hospital pharmacy : science and practice / Eur J Hosp Pharm. 2023 Nov;30(6):328-332. doi: 10.1136/ejhpharm-2021-002998. Epub 2022 Jan 20.
2023
ASL Torino 4
ASL Torino 4
Lasala R; Santoleri F; Romagnoli A; Abrate P; Musicco F; Costantini A;
Safety and Effectiveness of Multiple Switching Between Originators and Biosimilars: Literature Review and Status Report on Interchangeability. in Therapeutic innovation & regulatory science / Ther Innov Regul Sci. 2023 Mar;57(2):352-364. doi: 10.1007/s43441-022-00473-2. Epub 2022 Nov 2.
2023
ASL Torino 4
ASL Torino 4
Abrate P; Zovi A; Lasala R; Santoleri F;
A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions. in Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners / J Oncol Pharm Pract. 2023 Dec;29(8):1806-1815. doi: 10.1177/10781552221117135. Epub 2022 Jul 29.
2023
ASL Torino 4
ASL Torino 4
Musicco F; Lasala R; Santoleri F; Costantini A; Abrate P; Carretta MT; Proli EM; Romagnoli A; Petragnani N; Vita F; Zeuli M; Vici P; Sansone M; Pasquantonio M; La Malfa A; Fulgenzio C;
Randomized clinical trials and real life studies: Comparison of baseline characteristics of patients in oral target therapies for renal cell carcinoma. in Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners / J Oncol Pharm Pract. 2022 Jun;28(4):870-883. doi: 10.1177/10781552211005518. Epub 2021 Apr 13.
2022
ASL Torino 4
ASL Torino 4
Lasala R; Santoleri F; Romagnoli A; Musicco F; Abrate P; Costantini A;